Ken-ichi Kusakabe

Researcher
DISC Type : Cs

Director, Head of Neuroscience Chemistry at Shionogi & Co., Ltd

Osaka, Japan

Overview

Ken-ichi Kusakabe is a seasoned drug discovery leader and medicinal chemist with 20 years of experience at Shionogi & Co. , Ltd. , where he serves as Director and Head of Neuroscience Chemistry. He specializes in CNS drug design for neuroscience, immunology, and oncology, holding a Doctorate in Pharmaceutical Sciences from Kumamoto University.

He is passionate about advancing drug discovery, often sharing his teams research on novel approaches to CNS drug design and Alzheimers research with the broader scientific community. He is also focused on team building and recruiting top talent in medicinal chemistry.

His collaborative work with Janssen led to the discovery of Atabecestat, a BACE1 inhibitor that advanced to Phase 2b/3 clinical trials for Alzheimers disease.

Personality Overview

Process Focused

Cost Conscious

Self-Disciplined

They are always well-planned and adopt a systematic approach.  Being observant comes to them naturally. They do not like taking risks at all and go for proven options in the end.

Topics They Care About

CNS Drug Design
A primary focus of his work, he actively shares new methods for increasing CNS drug exposure and tackling challenges in neuroscience drug discovery.
Alzheimer's Research
He has led extensive research on β-Secretase (BACE1) inhibitors, discovering several clinical candidates like Atabecestat aimed at treating Alzheimer's disease.
Medicinal Chemistry
As a 20-year veteran, he is a leader in the field and is actively involved in hiring and developing medicinal chemists to drive innovation at Shionogi.

Media Appearances

Ken-ichi has no verified media appearances

Work History

4-2018
Director, Head of Neuroscience Chemistry at Shionogi & Co., Ltd
4-2015
Director, Head of Pain & Neuroscience Chemistry I at Shionogi & Co., Ltd
4-2007 - 3-2014
Team Lead at Shionogi & Co., Ltd
4-2000 - 3-2006
Scientist at Shionogi & Co., Ltd
5-1998 - 3-2000
Visiting Scientist at The University of Tokyo

Education

1994 - 2000
Master of Science - MS from Tokyo University of Science
2014 - 2014
Doctor of Phamaceutical Sciences from Kumamoto University

More Information

Social Presence :

Prographics :

Exp : 25 Location : Osaka, Japan Job Level : Mid-senior Designation : Director, Head of Neuroscience Chemistry at Shionogi & Co., Ltd
URL has been copied!

Insights For Selling To Ken-ichi

During A Call Or A Meeting

DO's

  • Share a one-off customer success story but keeps the focus on highlighting objective, numerical results
  • When following up with them, expect slowness; use questions to engage them, preferably over email.
  • Preferably use email to follow up with them instead of phone or Linkedin, engage by asking question or opinions

DONT's

  • Avoid emotional and informal language, stay objective and to the point instead
  • Avoid winging it with them particularly, answer a question only if you know the answer well
  • Don't ask them to move fast, let them take their time and digest all the information

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Ken-ichi is

  • Proof of usage by others in the industry, case studies showing ROI are likely to work the best with them.
  • Will you ever get a clear answer from Ken-ichi

  • They are unlikely to say no, it's better to stop yourself once you have exhausted all the options.

Insights For Deal Planning

    How fast (or slow) will Ken-ichi move?

  • They are some of the slowest movers and take their time reaching decisions.
  • Can Ken-ichi take some risk or not?

  • They have very low acceptance of risk even if they do not say it directly.

You And Ken-ichi

Personality Compatibility


Other Shionogi & Co., Ltd Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.